Cargando…
Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers
In response to the request of the European Commission to EFSA, this document provides guidance on the information necessary to perform the risk assessment of plant protection active substances that contain stereoisomers in their composition as active components or impurities. The guidance should als...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009100/ https://www.ncbi.nlm.nih.gov/pubmed/32626414 http://dx.doi.org/10.2903/j.efsa.2019.5804 |
_version_ | 1783495591765999616 |
---|---|
author | Bura, László Friel, Anja Magrans, José Oriol Parra‐Morte, Juan Manuel Szentes, Csaba |
author_facet | Bura, László Friel, Anja Magrans, José Oriol Parra‐Morte, Juan Manuel Szentes, Csaba |
collection | PubMed |
description | In response to the request of the European Commission to EFSA, this document provides guidance on the information necessary to perform the risk assessment of plant protection active substances that contain stereoisomers in their composition as active components or impurities. The guidance should also be used for active substances that without containing any stereogenic element may generate transformation products or metabolites that do contain them. As a general principle, stereoisomers need to be treated as different chemical components for the risk assessment. Current data requirements in the EU regulatory framework (Regulation (EC) No 1107/2009 and Regulation (EC) No 396/2005) already establish that the substance tested should match the technical specifications (including its isomeric composition) and that formation and effects of metabolites, degradation and transformation products should be investigated (which certainly includes the case when transformation products are stereoisomers). Experience gained during the application of EU pesticides regulation has shown that guidance may be needed to provide applicants and evaluators advice on how to generate and assess the required data. Also, guidance is needed on how to make the best use of the available information to perform the risk assessment of these substances, particularly in situations when the information on individual isomers is not available or difficult to obtain, with a primary objective being to reduce the need for repeating vertebrate animal testing. This guidance does not aim to provide specific technical advice on analytical methods. In this guidance, the Regulation (EU) 283/2013 on the data requirements for the plant protection active substances is analysed and recommendations are given on how to best address and assess data requirements for active substances containing stereoisomers. |
format | Online Article Text |
id | pubmed-7009100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70091002020-07-02 Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers Bura, László Friel, Anja Magrans, José Oriol Parra‐Morte, Juan Manuel Szentes, Csaba EFSA J Guidance Document In response to the request of the European Commission to EFSA, this document provides guidance on the information necessary to perform the risk assessment of plant protection active substances that contain stereoisomers in their composition as active components or impurities. The guidance should also be used for active substances that without containing any stereogenic element may generate transformation products or metabolites that do contain them. As a general principle, stereoisomers need to be treated as different chemical components for the risk assessment. Current data requirements in the EU regulatory framework (Regulation (EC) No 1107/2009 and Regulation (EC) No 396/2005) already establish that the substance tested should match the technical specifications (including its isomeric composition) and that formation and effects of metabolites, degradation and transformation products should be investigated (which certainly includes the case when transformation products are stereoisomers). Experience gained during the application of EU pesticides regulation has shown that guidance may be needed to provide applicants and evaluators advice on how to generate and assess the required data. Also, guidance is needed on how to make the best use of the available information to perform the risk assessment of these substances, particularly in situations when the information on individual isomers is not available or difficult to obtain, with a primary objective being to reduce the need for repeating vertebrate animal testing. This guidance does not aim to provide specific technical advice on analytical methods. In this guidance, the Regulation (EU) 283/2013 on the data requirements for the plant protection active substances is analysed and recommendations are given on how to best address and assess data requirements for active substances containing stereoisomers. John Wiley and Sons Inc. 2019-08-26 /pmc/articles/PMC7009100/ /pubmed/32626414 http://dx.doi.org/10.2903/j.efsa.2019.5804 Text en © 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Guidance Document Bura, László Friel, Anja Magrans, José Oriol Parra‐Morte, Juan Manuel Szentes, Csaba Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers |
title | Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers |
title_full | Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers |
title_fullStr | Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers |
title_full_unstemmed | Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers |
title_short | Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers |
title_sort | guidance of efsa on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers |
topic | Guidance Document |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7009100/ https://www.ncbi.nlm.nih.gov/pubmed/32626414 http://dx.doi.org/10.2903/j.efsa.2019.5804 |
work_keys_str_mv | AT guidanceofefsaonriskassessmentsforactivesubstancesofplantprotectionproductsthathavestereoisomersascomponentsorimpuritiesandfortransformationproductsofactivesubstancesthatmayhavestereoisomers AT buralaszlo guidanceofefsaonriskassessmentsforactivesubstancesofplantprotectionproductsthathavestereoisomersascomponentsorimpuritiesandfortransformationproductsofactivesubstancesthatmayhavestereoisomers AT frielanja guidanceofefsaonriskassessmentsforactivesubstancesofplantprotectionproductsthathavestereoisomersascomponentsorimpuritiesandfortransformationproductsofactivesubstancesthatmayhavestereoisomers AT magransjoseoriol guidanceofefsaonriskassessmentsforactivesubstancesofplantprotectionproductsthathavestereoisomersascomponentsorimpuritiesandfortransformationproductsofactivesubstancesthatmayhavestereoisomers AT parramortejuanmanuel guidanceofefsaonriskassessmentsforactivesubstancesofplantprotectionproductsthathavestereoisomersascomponentsorimpuritiesandfortransformationproductsofactivesubstancesthatmayhavestereoisomers AT szentescsaba guidanceofefsaonriskassessmentsforactivesubstancesofplantprotectionproductsthathavestereoisomersascomponentsorimpuritiesandfortransformationproductsofactivesubstancesthatmayhavestereoisomers |